UKRAIN: A NOVEL ANTITUMOR DRUG
UGLYANITSA K.N.,1 NEFYODOV L.I.,2 DOROSHENKO Y.M.,2 NOWICKY J.W.,3 VOLCHEK I.V.,5 BRZOSKO W.J.,4 HODYSH Y.J.3
1) Medical Institute of Grodno, Belarus.
2) Institute or Biochemistry, National Academy of Sciences, Grodno, Belarus.
3) Ukrainian Anti-Cancer Institute, Vienna, Austria.
4) Memorial Center of Natural Medicine, Warsaw, Poland.
5) Russian Medical Company, St. Petersburg, Russia.
Address for correspondence: K.N. Uglyanitsa, Medical Institute of Grodno, ul Gorkogo 80, 230015 Grodno, Belarus
Summary: A review of the recent literature on the new anticancer drug Ukrain is provided herein. We review Ukrain, a thiophosphate derivative of alkaloids from Chelidonium majus L., its capacity to exert selective cytotoxic and cytostatic effects on tumor cells, simultaneously acting as an immune response modifier, its good tolerance and lack of side effects even after long-term application, perspectives of the application of this drug in oncology.